1. Takakura H, Domae S, Ono T, Sasaki A. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma. Acta Med Okayama. 2017 Jun; 71(3): 219-226. 2. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010 Apr;39(4):299-305. 3. Hasina R, Lingen MW. Angiogenesis in oral cancer. J Dent Educ. 2001 Nov;65(11):1282-90. 4. Cohen ER, Reis IM, Gomez C, Pereira L,
Freiser ME, Hoosien G, et al. Immunohisto-chemistry analysis of CD44, EGFR, and p16 in oral cavity and oropharyngeal squamous cell carcinoma.
Otolaryngol Head Neck Surg. 2017 Aug; 157(2): 239-251. 5. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF
receptor. Cell. 2002 Sep 20;110(6):669-72. 6. Olapade-Olaopa EO, Moscatello DK, MacKay EH, Horsburgh T, Sandhu DP, Terry TR, et al.
Evidence for the differential expression of a
variant EGF receptor protein in human prostate cancer. Br J Cancer. 2000 Jan;82(1):186-94. 7. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, et al. Expression of C-erB-2 gene in human head and neck carci-noma. Anticancer Res. 1992 Nov-Dec; 12(6B):2273-6. 8. Sarkis SA, Abdullah BH, Abdul Majeed BA, Talabani NG. Immunohistochemical
expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in
relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis. Head Neck Oncol. 2010 Jun 25;2:13. 9. Baschnagel AM, Tonlaar N, Eskandari M,
Kumar T, Williams L, Hanna A, et al.
Combined CD44, c-MET, and EGFR
expression in p16-positive and p16-negative head and neck squamous cell carcinomas. J Oral Pathol Med. 2017 Mar;46(3):208-213. 10. Carballeira A, Ginarte M, Diniz-Freitas M, Fer-nández-Campos I, Gude F, Fraga M, et al.
Immunohistochemical evaluation of EGFR
expression in lip squamous cell carcinoma.
Correlation with clinicopathological
characteristics. Histol Histopathol. 2014 May; 29 (5):641-8. 11. Chandarana SP, Lee JS, Chanowski EJ, Sacco AG, Bradford CR, Wolf GT, et al. Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oro-pharyngeal and oral cavity cancer. Head Neck. 2013 Aug; 35(8): 1083-90. 12. Kontic M, Milovanovic J, Colovic Z, Poljak NK, Sundov Z, Sucic A, et al. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch
Otorhinolaryngol. 2015 Feb;272(2):401-5. 13. Sweeny L, Dean NR, Magnuson JS, Carroll WR, Helman EE, Hyde SO, et al. EGFR
expression in advanced head and neck cutane-ous squamous cell carcinoma. Head Neck. 2012 May; 34(5):681-6. 14. Wu SG, Chang YL, Lin JW, Wu CT, Chen HY, Tsai MF, et al. Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs
response prediction. PLoS One. 2011;6(8):e23303. 15. Yu J, Kane S, Wu J, Benedettini E, Li D, Reeves C, et al. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res. 2009 May 1;15(9): 3023-8. 16. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Immunohistochemical detection of p53 protein in mammary carcinoma: an im-portant new independent indicator of progno-sis? Hum Pathol. 1993 May;24(5):469-76. 17. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induc-tion of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997 Jul 11;277 (5323):225-8. 18. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, et al.
Characterization, quantification, and potential
clinical value of the epidermal growth factor
receptor in head and neck squamous cell
carcinomas. Head & neck. 1991 Mar-Apr; 13(2): 132-9. 19. Taoudi Benchekroun M, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, et al. Epidermal growth factor
receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010 Jul;3(7):800-9. 20. Rogers SJ, Harrington KJ, Rhys-Evans P,
O-Charoenrat P, Eccles SA. Biological
significance of c-erbB family oncogenes in head and neck cancer. Can-cer Metastasis Rev. 2005 Jan;24(1):47-69. 21. Szentkúti G, Dános K, Brauswetter D, Kiszner G, Krenács T, Csákó L, et al. Correlations be-tween prognosis and regional biomarker profiles in head and neck squamous cell carcinomas. Pathol Oncol Res 2015 Jul;21(3):643-50. 22. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, et al. High EGFR
expression predicts poor prognosis in patients with Oral squamous cell carcinoma of the oral cavity and oropharynxs. Oral Oncol. 2007 Feb;43(2):193-8. 23. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, et al. Expression of cerbB2 gene in human head and neck carcino-ma. Anticancer Res. 1992 Nov-Dec; 12(6B):2273-6. 24. Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell
carcinomas. Pathol Oncol Res. 2006;12(2):87-91. 25. Bagan JV, Mata-Roig M, Cortio-Gimeno J, Murillo-Cortes J, Hens-Aumente E, Poveda-Poveda-Roda R, et al. Epidermal growth factor receptor copy number in potentially malignant oral
disorders and oral squamous cell carcinoma: a short communication and preliminary study. J Oral Pathol Med. 2012 Oct;41(9):662-6. 26. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A, Feinmesser R. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral On-col. 2004 May;40(5):532-7. 27. Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Aguiar MC. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell
carcinoma: a case control study. J Exp Clin
Cancer Res. 2010 Apr 29;29:40. 28. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002 Dec 15;62 (24):7350-6. 29. Keren S, Shoude Z, Lu Z, Beibei Y. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Tumour
Biol. 2014 Mar;35(3):2285-95. 30. Sun W, Long G, Wang J, Mei Q, Liu D, Hu G. Prognostic role of epidermal growth factor re-ceptor in nasopharyngeal carcinoma: a meta-analysis. Head Neck. 2014 Oct;36(10):1508-16. 31. Perisanidis C, Wrba F, Brandstetter A, Kornek G, Mitchell D, Seemann R, et al. Impact of
epidermal growth factor receptor, mesenchy-mal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2013 Apr;51(3):234-40. 32. Monteiro L, Ricardo S, Delgado M, Garcez F, do Amaral B, Lopes C. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas. Oral Dis. 2014 Mar;20(2):178-85. 33. Eriksen JG, Steiniche T, Askaa J, Alsner J, Overgaard J. The prognostic value of epidermal growth factor receptor is related to tumor
differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):561-6. 34. Giralt J, de las Heras M, Cerezo L, Eraso A, Hermosilla E, Velez D, et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multi-center,
retrospective analysis. Radiother Oncol. 2005 Feb; 74(2):101-8. 35. Yamada T, Takaga M, Shiodas S. Evaluation of EGFR in SCC of oral cavity. Oral Surg Oral
Med Oral Pathol. 1992 Jan;73(1):67-70. 36. Eicheler W, Krause M, Hessel F, Zips D,
Baumann M. Kinetics of EGFR expression dur-ing fractionated irradiation varies between dif-ferent human squamous cell carcinoma lines in nude mice. Radiother Oncol. 2005 Aug;76(2):151-6.
|